CanSino Biologics Inc Sustainability Reports

CanSino Biologics Inc. develops, manufactures, and commercializes human vaccines for the prevention and treatment of infectious diseases.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

LEI: 254900SPBQ0ZVM8QC931

FIGI: BBG00NN6QG24

12 reports from 2018 to 2025

• CanSino Biologics Inc 2025 Environmental, Social and Governance (ESG) & Sustainability Report
• CanSino Biologics Inc 2025 Annual Report
• CanSino Biologics Inc 2024 Annual Report
• CanSino Biologics Inc 2024 Environmental, Social and Governance (ESG) & Sustainability Report
• CanSino Biologics Inc 2023 Environmental, Social and Governance & Corporate Social Responsibility Report